RABEPRAZOLE SODIUM
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72888-059 -
Package NDC
72888-059-30 -
Package NDC
72888-059-90 -
Application number
ANDA204237 -
SPL ID
4844a51a-513a-8b72-e063-6294a90ab996 -
SPL set ID
b1a12c83-74ab-febc-e053-2a95a90a1441 -
UNII
3L36P16U4R -
RxCUI
854868
What the source publishes
- Labeler
- Advagen Pharma Limited
- Active ingredients
- rabeprazole sodium
- Form
- TABLET, DELAYED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "RABEPRAZOLE SODIUM",
"splId": "4844a51a-513a-8b72-e063-6294a90ab996",
"labels": [
{
"setId": "b1a12c83-74ab-febc-e053-2a95a90a1441",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1a12c83-74ab-febc-e053-2a95a90a1441",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1a12c83-74ab-febc-e053-2a95a90a1441"
}
],
"routes": [
"ORAL"
],
"labeler": "Advagen Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-30)",
"package_ndc": "72888-059-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20170601"
},
{
"sample": false,
"description": "90 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-90)",
"package_ndc": "72888-059-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20170601"
}
],
"productId": "72888-059_4844a51a-513a-8b72-e063-6294a90ab996",
"useDomain": "unknown",
"dosageForm": "TABLET, DELAYED RELEASE",
"productNdc": "72888-059",
"deaSchedule": null,
"genericName": "rabeprazole sodium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RABEPRAZOLE SODIUM",
"strength": "20 mg/1"
}
],
"applicationNumber": "ANDA204237",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170601",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0372888059907",
"0372888059303"
],
"unii": [
"3L36P16U4R"
],
"rxcui": [
"854868"
],
"spl_set_id": [
"b1a12c83-74ab-febc-e053-2a95a90a1441"
],
"manufacturer_name": [
"Advagen Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72888-059_4844a51a-513a-8b72-e063-6294a90ab996"